Detection of YMDD motif mutants by oligonucleotide chips in lamivudine-untreated patients with chronic hepatitis B virus infection

Journal of Korean Medical Science

Volumn 19, Issue 4, 2004, Pages 541-546

  Heo, Jeong ^a   Cho, Mong ^a   Hyung, Hoi Kim ^a   Young, Min Shin ^a   Hyun, Jung Jang ^b   Hee, Kyung Park ^a   Cheol, Min Kim ^a   Gwang, Ha Kim ^a   Dae, Hwan Kang ^a   Geun, Am Song ^a   Ung, Suk Yang ^a  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

Hepatitis B, Chronic; Hepatitis, Viral; Lamivudine; Oligonucleotide Array Sequence Analysis; Polymorphism (Genetics); YMDD Motif Mutants

Indexed keywords

LAMIVUDINE;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ARTICLE; BLOOD ANALYSIS; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PROTEIN MOTIF; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SERUM; VIRUS MUTATION; WILD TYPE;

EID: 4444356037     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2004.19.4.541     Document Type: Article

References (10)

1. Liaw YF, Leung NW, Chang TT, Guan R, Tai DI, Ng KY, Chien RN, Dent J, Roman L, Edmundson S, Lai CL. Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. Gastroenterology 2000; 119: 172-80.
2. Leung NW, Lai CL, Chang TT, Guan R, Lee CM, Ng KY, Lim SG, Wu PC, Dent JC, Edmundson S, Condreay LD, Chien RN. On behalf of the Asia Hepatitis Lamivudine Study Group. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy. Hepatology 2001; 33: 1527-32.
3. Lau DT, Khokhar MF, Doo E, Ghany MG, Herion D, Park Y, Kleiner DE, Schmid P, Condreay LD, Gauthier J, Kuhns MC, Liang TJ, Hoofnagle JH. Long- term therapy of chronic hepatitis B with lamivudine. Hepatology 2000; 32: 828-34.
4. Chayama K, Suzuki Y, Kobayashi M, Kobayashi M, Tsubota A, Hashimoto M, Miyano Y, Koike H, Kobayashi M, Koida I, Arase Y, Saitoh S, Murashima N, Ikeda K, Kumada H. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy. Hepatology 1998; 27: 1711-6.
5. Paik YH, Chung HY, Ryu WS, Lee KS, Lee JS, Kim JH, Lee CK, Chon CY, Moon YM, Han KH. Emergence of YMDD motif mutant of hepatitis B virus during short-term lamivudine therapy in South Korea. J Hepatol 2001; 35: 92-8.
6. Perrillo R, Rakela J, Dienstag J, Levy G, Martin P, Wright T, Caldwell S, Schiff E, Gish R, Villeneuve JP, Farr G, Anschuetz G, Crowther L, Brown N. Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group. Hepatology 1999; 29: 1581-6.
7. Liaw YF, Chien RN, Yeh CT, Tsai SL, Chu CM. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy. Hepatology 1999; 30: 567-72.
8. Nafa S, Ahmed S, Tavan D, Pichoud C, Berby F, Stuyver L, Johnson M, Merle P, Abidi H, Trepo C, Zoulim F. Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B. Hepatology 2000; 32: 1078-88.
9. Mikhailovich V, Lapa S, Gryadunov D, Sobolev A, Strizhkov B, Chernyh N, Skotnikova O, Irtuganova O, Moroz A, Litvinov V, Vladimirskii M, Perelman M, Chernousova L, Erokhin V, Zasedatelev A, Mirzabekov A. Identification of rifampin-resistant Mycobacterium tuberculosis strains by hybridization, PCR, and lipase detection reaction on oligonucleotide microchips. J Clin Microbiol 2001; 39: 2531-40.
10. Zoulim F. Detection of hepatitis B virus resistance to antivirals. J Clin Virol 2001; 21: 243-53.